These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1179 related articles for article (PubMed ID: 23768643)
1. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas. Shustov A Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643 [TBL] [Abstract][Full Text] [Related]
2. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation. Gkotzamanidou M; Papadimitriou CA Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060 [TBL] [Abstract][Full Text] [Related]
3. Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma. Dreger P; Laport GG Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):100-7. PubMed ID: 18162229 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. NK/T-cell lymphomas in children. Lai C; Dunleavy K Best Pract Res Clin Haematol; 2013 Mar; 26(1):33-41. PubMed ID: 23768639 [TBL] [Abstract][Full Text] [Related]
7. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703 [TBL] [Abstract][Full Text] [Related]
8. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis. El-Asmar J; Reljic T; Ayala E; Hamadani M; Nishihori T; Kumar A; Kharfan-Dabaja MA Biol Blood Marrow Transplant; 2016 May; 22(5):802-14. PubMed ID: 26713431 [TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110 [TBL] [Abstract][Full Text] [Related]
11. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. Corradini P; Dodero A; Zallio F; Caracciolo D; Casini M; Bregni M; Narni F; Patriarca F; Boccadoro M; Benedetti F; Rambaldi A; Gianni AM; Tarella C J Clin Oncol; 2004 Jun; 22(11):2172-6. PubMed ID: 15169805 [TBL] [Abstract][Full Text] [Related]
13. The role of high-dose therapy in peripheral T-cell lymphomas. Reimer P; Rüdiger T; Wilhelm M Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812 [TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma. Rogers AM; Brammer JE Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515 [TBL] [Abstract][Full Text] [Related]
16. International analysis of the frequency and outcomes of NK/T-cell lymphomas. William BM; Armitage JO Best Pract Res Clin Haematol; 2013 Mar; 26(1):23-32. PubMed ID: 23768638 [TBL] [Abstract][Full Text] [Related]